FDA declines approval bid for Neffy, a needle-free EpiPen alternative

ASR Pharma said it was surprised and "deeply disappointed" by the FDA request for more trial data on its Neffy nasal spray for severe allergic reactions.

• Sep 20, 2023

FDA rejects approval of epinephrine nasal spray

The Food and Drug Administration on Tuesday declined to approve Neffy, an epinephrine nasal spray that offers a needle-free alternative for treating severe allergic reactions. The FDA said Neffy needs more research.

• Sep 20, 2023
• 0:16

Some expired COVID tests are still effective

The Food and Drug Administration recently determined some expired COVID-19 tests may still be safe and effective at detecting infections. CBS MoneyWatch reporter Megan Cerullo explains how people can check if their at-home test kits are still valid.

• Sep 15, 2023
• 3:17

FDA panel: Common decongestant doesn't work

An FDA advisory panel found the common decongestant phenylephrine, which is found in many over-the-counter cold and allergy medicines, doesn't work. CBS News chief medical correspondent Dr. Jon LaPook joins 'CBS Mornings' to discuss.

• Sep 13, 2023
• 3:46

FDA panel says common decongestant doesn't work

An FDA panel said phenylephrine, a nasal decongestant found in many over-the-counter medications, doesn't actually work.

• Sep 12, 2023
• 0:21

Ineffective ingredient could spell the end of Dayquil, Sudafed, others

FDA's phenylephrine findings could leave consumers scrambling to find alternatives for relief from mild illnesses like nasal congestion.

• Sep 12, 2023

CDC expected to recommend updated COVID booster

The FDA has approved updated COVID vaccines that should protect people against recent variants of the virus. Dr. Celine Gounder explains who should get vaccinated and how the vaccines work.

• Sep 12, 2023
• 3:37

FDA approves new COVID boosters

The FDA has approved new COVID-19 boosters designed to target the current dominant variant. The new shots could roll out as early as this week if the Centers for Disease Control and Prevention also approves them.

• Sep 11, 2023
• 0:20

Breaking down Biden's drug price plan

The Biden administration has named 10 prescription drugs it hopes to make cheaper for Medicare recipients through negotiations with drug companies. The White House says the drugs on the list include Jardiance for diabetes and the blood thinner Eliquis. CBS News senior White House and political correspondent Ed O'Keefe has more details.

• Aug 29, 2023
• 4:12

First RSV vaccine for pregnant women OK'd

The FDA has approved the first vaccine against RSV for pregnant women to pass protection to their newborns. Dr. Celine Gounder explains how it works, and when women should get it.

• Aug 22, 2023
• 2:32

Nestlé recalls cookie dough bars that may contain wood fragments

The recall comes in response to "a small number" of calls from consumers, though no injuries or illnesses have been reported.

• Aug 14, 2023

Ice cream sold in 19 states is recalled due to listeria outbreak

Two people — one each in New York and Pennsylvania — have been hospitalized after eating Soft Serve On The Go.

• Aug 11, 2023

FDA approves pill for postpartum depression

The FDA on Friday announced its approval of an oral treatment for postpartum depression. The drug, called zuranolone, is a once-a-day pill. Roxana Saberi has more on how the pill can help women deal with one of the most common medical complications after pregnancy.

• Aug 5, 2023
• 2:01

Thousands of birth control pills recalled, may be ineffective, FDA warns

Testing revealed some lots of the Tydemy birth control tablets did not have enough of a key ingredient.

• Aug 2, 2023

Researchers say another Alzheimer's drug slows disease by a few months

Eli Lilly's experimental Alzheimer's drug donanemab​ can modestly slow the worsening of the disease by about four to seven months, according to researchers.

• Jul 18, 2023

4/28: CBS News Mornings

Moderna asks FDA to authorize vaccine for young kids; Southen California water restrictions imposed.

• Apr 28, 2022
• 46:07

Kratom products draw criticism from health experts

The Food and Drug Administration says the controversial herbal supplement kratom "exposes users to the risks of addiction, abuse, and dependence." Mark Strassman reports.

• Jul 15, 2023
• 3:05

FDA approves the first OTC birth control

The Food and Drug Administration has approved the first over-the-counter birth control pill, Opill. Anyone of reproductive age will be able to obtain it without a prescription or parental approval. Opill will be available in pharmacies, grocery stores and online. Janet Shamlian has more.

• Jul 14, 2023
• 2:05

Is aspartame safe? Here's a list of products that use it.

Many popular diet sodas, light gelatins and sugar-free gums contain the artificial sweetener.

• Jul 14, 2023

FDA approves first over-the-counter birth control pill

The U.S. Food and Drug Administration approved the first over-the-counter birth control pill​, allowing Americans to buy Opill, a daily oral contraceptive, without a prescription.

• Jul 13, 2023

Does aspartame have health risks? What to know about the popular sweetener.

The artificial sweetener aspartame is used in thousands of products, and the FDA says it's "safe for the general population." What do we know about its possible effects on health?

• Jul 13, 2023

Impact of approval for OTC birth control pill

The Food and Drug Administration has approved the first over-the-counter birth control pill. This means Americans will be able to purchase a daily oral contraceptive without a prescription in stores or online starting in early 2024. Dr. Shoshana Ungerleider, an internal medicine physician and the host of the podcast "TED Health," joined CBS News to talk about the approval.

• Jul 13, 2023
• 4:16

Sen. Schumer urges FDA probe into PRIME

Sen. Charles Schumer is asking the Food and Drug Administration to investigate PRIME's high-caffeine energy drink. The brand is founded by YouTube stars Logan Paul and KSI.

• Jul 10, 2023
• 1:11

FDA fully approves Alzheimer's drug Leqembi

The FDA has approved a drug for people in the early stages of Alzheimer's disease. CBS News' chief medical correspondent Dr. Jon LaPook explains how it works, the risks and who might benefit.

• Jul 7, 2023
• 5:48

FDA approves Alzheimer's drug Leqembi

The Food and Drug Administration on Thursday gave its approval to Leqembi, a drug designed to slow the progression of Alzheimer's disease. Leqembi is not considered a cure for Alzheimer’s, but will be covered by Medicare. Dr. Jon LaPook has more.

• Jul 6, 2023
• 2:14

Show More